EGFR and lung adenocarcinoma: A study by Nguyen et al. using 139 lung adenocarcinoma also reported that EGFR mutations were more common in females (p < 0.001), but there was no sex difference in EGFR methylation (p = 0.893) or EGFR overexpression [38].